Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Promising phase II data presented for olamkicept in ulcerative colitis

April 27, 2021

Enrollment opens in phase II study of RO-7049665 in autoimmune hepatitis

April 20, 2021

Medshine Discovery patents CRAC blockers

April 16, 2021

Thyroid hormone receptor beta agonists discovered at Sunshine Lake Pharma

April 15, 2021

First patient dosed in phase Ib/IIa study SYN-004 in allogeneic HCT recipients

April 15, 2021

New agonist MAb resolves chronic inflammation

April 14, 2021

FDA clears IND application for phase IIb study of AXA-1125 in NASH

April 14, 2021

Terns identifies thyroid hormone receptor beta agonists

April 8, 2021

Landos' IND for omilancor in eosinophilic esophagitis cleared in U.S.

April 7, 2021

Enrollment commences in phase I study of recombinant IAP SYN-020

April 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...